Latest News and Press Releases

Oslo, Oct 1, 2018 - Navamedic ASA (OSE: NAVA) today announces that Tom Rönnlund has tendered his resignation as CEO of Navamedic ASA and will leave the company at the end of 2018 to take up a position...

  Oslo, 24. august 2018 - Navamedic ASA (OSE: NAVA) rapporterte driftsinntekter på NOK 45,2 millioner i andre kvartal 2018, ned fra NOK 89,7 millioner i samme periode i 2017, etter det planlagte...

  Oslo, August 24, 2018 - Navamedic ASA (OSE: NAVA) reported revenues of NOK 45.2 million in the second quarter of 2018, down from NOK 89.7 million in the same period in 2017, following the...

Oslo, 24. august 2018 - Navamedic ASA (OSE: NAVA) rapporterte driftsinntekter på NOK 45,2 millioner i andre kvartal 2018, ned fra NOK 89,7 millioner i samme periode i 2017, etter det planlagte utløpet...

Oslo, August 24, 2018 - Navamedic ASA (OSE: NAVA) reported revenues of NOK 45.2 million in the second quarter of 2018, down from NOK 89.7 million in the same period in 2017, following the planned...

  Oslo, August 21, 2018 - Navamedic ASA (OSE: NAVA) today announced it has renewed three partnership agreements with Vitaflo International Limited, Allerderm Laboratories and Qiagen GmbH for...

Navamedic ASA invites you to a presentation of the second quarter 2018 figures. The presentation will take place at Felix Konferansesenter, Aker Brygge, Oslo, Friday 24 August. The presentation will...

Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, announced today that it has entered a contract with Västra Götalands Regionen (VGR) on its proprietary...

  Navamedic ASA has today, 7 June 2018, held an annual general meeting. All resolutions were made in accordance with the board's/nomination committee's proposals. The minutes from the general...

  On the basis of the approval by the Annual General Meeting of June 6th 2017, to authorize the Board to issue 150 000 new shares to management under a long-term incentive program, the Board has...